Cost of CIN Calculator

%
Total at Risk Population patients
%
night(s)
Average additional hospitalization days for CIN1 3.75 day(s)
$
$
Cost of Hydration Per Patient $
Cost Per CIN Patient $
Number CIN Patients patients
Total CIN Cost (prevention and treatment) $
Cost Per At-risk Patient $

Estimated Cost Reduction Using RenalGuard

$
%
Patients on RenalGuard patients
Total RenalGuard Cost $
%
%
Number CIN Patients Among Treated
(based on percent CIN reduction)
patients
Cost Per CIN Patient
(based on dialysis reduction)
$
Cost of Untreated Patients $
Total CIN Cost $
CIN + RenalGuard $
Total Savings $
Savings per patient treated $

Reset

1 Subramanian S et al. Economic burden of contrast-induced nephropathy: implications for prevention strategies. Journal of Medical Economics. 2007;10(2):119–134.

2 Marenzi G et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. JACC. Cardiovascular interventions. 2012;5(1):90–7.

3 Briguori C. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2011;6(9):1117–1122, 7.